Investors

SEC Filings

SEC Filings

Filing date	Form	Description	View
April 30, 2015	DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	0001193125-15-159076.pdf 0001193125-15-159076.rtf 0001193125-15-159076.xls View HTML
April 29, 2016	DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	0001193125-16-569284.pdf 0001193125-16-569284.rtf 0001193125-16-569284.xls View HTML
May 1, 2017	DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	0001193125-17-151781.pdf 0001193125-17-151781.rtf 0001193125-17-151781.xls View HTML
April 30, 2018	DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	0001193125-18-143058.pdf 0001193125-18-143058.rtf 0001193125-18-143058.xls View HTML
April 26, 2019	DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	0001193125-19-122303.pdf 0001193125-19-122303.rtf 0001193125-19-122303.xls View HTML
April 23, 2020	DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	0001193125-20-117181.pdf 0001193125-20-117181.rtf 0001193125-20-117181.xls View HTML
April 22, 2021	DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	0001193125-21-126686.pdf 0001193125-21-126686.rtf 0001193125-21-126686.xls View HTML
April 28, 2022	DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	0001193125-22-125281.pdf 0001193125-22-125281.rtf 0001193125-22-125281.xls View HTML
March 1, 2023	DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	0001193125-23-056298.pdf 0001193125-23-056298.rtf 0001193125-23-056298.xls View HTML
April 28, 2023	DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	0001193125-23-124284.pdf 0001193125-23-124284.rtf 0001193125-23-124284.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML

Data provided by Kaleidoscope.

Print Page

Email Page

Contact IR

Email Alerts

Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098 phone
+1 617.871.2099 fax